NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) IPO

NeuroSense Therapeutics Ltd.

IPO

Priced at US$6.00 a unit on Dec 8, 2021.

Price
US$6.00 a unit
Units offered
2,000,000 units
Offering size
US$12 million
Underwriters' option
Up to 300,000 more units
Listing
NRSN on the Nasdaq Capital Market
Underwriter
Sole Book-Running Manager Maxim Group LLC
Units delivered
On or about Dec 13, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceAug 10, 2021
Filed publiclyOct 18, 2021
Amended 4 timesNewest Dec 6, 2021
Shares registered with an exchangeNov 18, 2021
Declared effective by the SECDec 8, 2021
Final prospectus, with the priceDec 10, 2021

From the cover of the final prospectus (424B4) filed Dec 10, 2021